Faruk Skenderi, MD, PhD

Pathologist, Assistant Professor

Affiliations

Department of Pathology, Medical School, Sarajevo School of Science and Technology
E-mail: faruk.skenderi@biomolbiomed.com

EDUCATION AND TRAINING

  • Doctor of Science (Ph.D.), Pathology, University of Zagreb School of Medicine, Croatia (2021)
  • Pathologist, Board-certified (2017)
  • Pathology Resident, University of Sarajevo Clinical Center (2012 – 2017)
  • Master of Science (MSc), University of Sarajevo, Bosnia and Herzegovina and University of Rijeka, Croatia (2009 – 2011)
  • Research fellow, Center for Proteomics, University of Rijeka, Croatia (2009 – 2010)
  • Medical Doctor (MD), University of Sarajevo Faculty of Medicine, Bosnia and Herzegovina (2007)

PROFESSIONAL EXPERIENCE

  • Head of Pathology Lab, UniMed, Sarajevo School of Science and Technology (2023 – present)
    • Overseeing diagnostic pathology service and laboratory management
  • CEO and consultant, GenoLab Ltd. (2021- present)
    • Providing precision medicine services and consultations
  • Pathologist, University of Sarajevo Clinical Center (2017 – 2021)
    • Specialized in tissue and biomarker analysis of breast lesions as a member of a multidisciplinary breast cancer treatment team
  • Pathology resident, University of Sarajevo Clinical Center (2012-2017)

TEACHING EXPERIENCE

  • Assistant professor of Pathology, Medical School, Sarajevo School of Science and Technology (2023 – present)
    • Teaching Pathology to medical students
  • Lecturer, University of Sarajevo Faculty of Health Sciences (2015 – 2022)
    • Undergraduate courses in Pathology and Pathophysiology, Histopathology techniques, Morphology methods for students of Health Sciences
  • Lecturer, University of Sarajevo Medical Faculty (2017 – 2019)
    • Undergraduate courses in Pathology for medical school students
  • Teaching and research assistant, University of Sarajevo Medical Faculty (2007-2011)
    • Courses in Biochemistry for medical school students

EDITORIAL AND LEADERSHIP ROLES

  • Managing Editor, Biomolecules and Biomedicine (formerly BJBMS) (2014 – present)
  • Associate Editor, BMC Cancer Cell International (2019 – 2020)
  • President, Association of Pathologists and Cytologists of FBIH (2019 – present)

WORKSHOPS AND SYMPOSIA

  • Organizer, Bryan Warren School of Pathology (2012 – present)
  • Organizer, Bosnian Turkish School of Cytopathology (2016 – present)

SKILLS

  • Diagnostic and research histopathology (breast pathology, kidney pathology)
  • Diagnostic and research immunohistochemistry (IHC) and In situ hybridization (ISH)
  • Hybridoma and monoclonal antibody technology
  • Cell lines, Flow cytometry, PCR, Western blot, ELISA

MEMBERSHIPS

  • United States and Canadian Academy of Pathology (USCAP)
  • European Society of Pathology (ESP)
  • International Society for Urological Pathology (ISUP)
  • Association of Pathologists and Cytologists of FBIH
  • Association of Basic Medical Sciences of FBIH

AWARDS

  • USCAP Global Partner award (2021, 2019)
  • BDIAP Nermin Durakovic award (2018, 2014)
  • Marie Curie Actions, Early-stage research fellow (2009 – 2010)
  • Erasmus Mundus Basileus fellowship (2009)
  • Dean’s award for excellence (2006)

PEER REVIEWER

PUBLICATIONS

  1. Tomic K, Karan Krizanac D, Skenderi F, Krpina K, Carapina Bilic A, Galic K, Gatalica Z, Vranic S. Comprehensive genomic profiling of a metastatic small cell lung carcinoma with a complete and long-term response to atezolizumab: A case report. Respiratory Med Case Reports 2023;45:101920, https://doi.org/10.1016/j.rmcr.2023.101920
  2. Mujic M, Vranic S, Skenderi F.  Bosnian Journal of Basic Medical Sciences becomes Biomolecules and Biomedicine.  2023 Feb 1;23(1):1. doi: 10.17305/bjbms.2022.8686.
  3. Ajkunic A, Skenderi F, Shaker N, Akhtar S, Lamovec J, Gatalica Z, Vranic S. Acinic cell carcinoma of the breast: A comprehensive review. Breast. 2022 Dec;66:208-216. doi: 10.1016/j.breast.2022.10.012. Epub 2022 Oct 28.
  4. Alaghehbandan R, Agaimy A, Ali L, Alvarado-Cabrero I, Amin MB, Boudova L, Caliò A, Comperat EM, Damjanov I, Daum O, Farcas M, Gatalica Z, Gill AJ, Hartmann A, Hayes MM, Hora M, Kojima F, Kristiansen G, Kuroda N, López JI, Maclean F, Magi-Galluzzi C, Martignoni G, McKenney JK, Michalová K, Michal M, Mohanty SK, Netto GJ, Ohashi R, Ondič O, Osunkoya AO, Gomez MDPM, Petersson F, Picken MM, Pivovarcikova K, Rogala J, Shah RB, Siadat F, Skenderi F, Sperga M, Suster SM, Svajdler M, Tretiakova M, Trpkov K, Ulamec M, Williamson SR, Yang XJ, Zhou M, Vranic S, Vujanic G, Michal M. A tribute to Prof. Ondrej Hes, MD, PhD (1968-2022). Mod Pathol. 2022 Dec;35(12):2023-2024. doi: 10.1038/s41379-022-01159-8.
  5. Kolar J, Llaurado AF, Ulamec M, Skenderi F, Perez-Montiel D, Alvarado-Cabrero I, … Hes O. Histologic diversity in chromophobe renal cell carcinoma does not impact survival outcome: A comparative international multi-institutional study. Ann Diagn Pathol. 2022 May 20;60:151978. doi: 10.1016/j.anndiagpath.2022.151978.
  6. Skenderi F, Mohamad Alahmad MA, Tahirovic E, Alahmad YM, Gatalica Z, Vranic S. HER2-positive Apocrine Carcinoma of the Breast: A population-based Analysis of Treatment and Outcome. Breast Cancer Res Treat. 2022 Jun;193(2):523-533. doi: 10.1007/s10549-022-06578-4
  7. Zvizdic Z, Selimovic M, Mesic A, Anic D, Misanovic V, Skenderi F, Vranic S. Unexpected adrenal pheochromocytoma associated with a generalized tonic-clonic seizure in a prepubertal boy: A case report and literature review. Medicine (Baltimore) 2021;100(4):p e24303 doi: 10.1097/MD.0000000000024303.
  8. Kruslin B, Gatalica Z, Hes O, Skenderi F, Miettinen M, Vranic S, … Swensen J. TERT gene fusions characterize a subset of metastatic Leydig cell tumors. Clinical Genitourinary Cancer 2021 Feb 17 Ahead of Print, https://doi.org/10.1016/j.clgc.2021.02.002.
  9. Ibisevic N, Bajrovic J, Spiritovic D, Saranovic E, Skenderi F, Vranic S. A giant, complex fibroepithelial tumor of the breast: Borderline phyllodes combined with tubular adenoma. A rare clinical presentation of a fibroepithelial tumor of the breast. Acta Medica Academica 2021, link: http://www.ama.ba/upcoming/Acta%20Medica%20Academica%201-2021-Ibisevic1.pdf.
  10. Zvizdic D, Bulja D, Sidran A, Skenderi F, Zvizdic Z, Vranic S. Isolated orbital hemangioma treated successfully with oral propranolol in a 2-month-old infant: Case report and literature review. Am J Ophthalmology Case Report 2021;22:101095, https://doi.org/10.1016/j.ajoc.2021.101095.
  11. Catic A, Kurtovic-Kozaric A, Sophian A, Mazur L, Skenderi F, Hes O, Rohan S, Rakheja D, Kogan J, Pins MR. KANK1-NTRK3 fusions define a subset of BRAF mutation negative renal metanephric adenomas. BMC Med Genet. 2020 Oct 12;21(1):202. https://doi.org/10.1186/s12881-020-01143-6
  12. Al-Thawadi H, Jabeen A, Gupta I, Skenderi F, Sharma A, Vranic S, Al Moustafa AE. Co-Presence of Human Papillomaviruses and Epstein–Barr Virus is Linked with Advanced Tumor Stage: A Tissue Microarray Study in Head and Neck Cancer Patients. Cancer Cell Int 2020;20:361, https://doi.org/10.1186/s12935-020-01348-y
  13. Zvizdic Z, Moinuddin Z, Summers A, Pasic-Sefic I, Skenderi F, Van Dellen D, Vranic S, Augustine T. A Successful treatment of encapsulating peritoneal sclerosis in an adolescent boy on long-term peritoneal dialysis: A case report. Prague Med Rep 2020, in press.
  14. Skenderi F, Palazzo J, Swensen J, Feldman R, Contreras E, Florento E, Gatalica Z, Vranic S. Novel Targetable Biomarkers in Clear Cell Carcinoma of the Breast Uncovered by Molecular Profiling: A study of nine cases. Breast J. 2020 Sep;26(9):1781-1783. doi: 10.1111/tbj.13842. Epub 2020 Apr 11.
  15. Bešlija S, Gojković Z, Cerić T, Mekić Abazović A, Marijanović I, Vranić S, Mustedanagić–Mujanović J, Skenderi F, Rakita I, et al. 2020 consensus guideline for optimal approach to the diagnosis and treatment of HER2-positive breast cancer in Bosnia and Herzegovina. Bosn J Basic Med Sci. 2021 Apr 1;21(2):120-135. doi: 10.17305/bjbms.2020.4846.
  16. Zvizdic Z, Rustempasic N, Sefic Pasic I, Skenderi F, Vranic S. A case of extra-adrenal retroperitoneal ganglioneuroma enclosing large blood vessels in a 9-year-old female: A report of rare case and comprehensive literature review. Central J Eur Paediatrics 2020.
  17. Gupta I, AlFarsi H, Jabeen A, Skenderi F, Al-Thawadi H, AlAhmad YM, Al Moustafa AE, Vranic S. High-risk Human Papillomaviruses and Epstein-Barr virus in Colorectal Cancer and their Association with Clinicopathological Status. Pathogens (Basel) 2020;9(6):E452. doi: https://doi.org/10.3390/pathogens9060452
  18. Moran CA, Lindholm KE, Brunnström H, Langman G, Jang SJ, Spagnolo D, Chai SM, Laycock A, Falconieri G, Pizzolitto S, de Pellegrin A, Medeiros F, Edmunds L, Catarino A, Cunha F, Ro J, Pina-Oviedo S, Torrealba J, Coppola D, Petersson F, Oon ML, Elmberger G, Y Cajal SR, Valero IS, Dalurzo L, Soares F, Campos AH, Vranic S, Skenderi F, Correa AM, Sepesi B, Rice D, Mehran R, Walsh G.Typical and atypical carcinoid tumors of the lung: a clinicopathological correlation of 783 cases with emphasis on histological features.  Hum Pathol. 2020 Apr;98:98-109. doi: 10.1016/j.humpath.2020.02.005. Epub 2020 Mar 5.
  19. Vranic S, Skenderi F, Beslagic V, Gatalica Z. Glycogen-rich clear cell carcinoma of the breast: A concise review. Appl Immunohistochem Mol Morphol 2020 Mar 11. doi: 10.1097/PAI.0000000000000850.
  20. Vranic S, Stafford P, Palazzo J, Skenderi F, Swensen J, Xiu J, Spetzler D, Gatalica Z. Molecular profiling of the metaplastic spindle cell carcinoma of the breast reveals potentially targetable biomarkers. Clin Breast Cancer. 2020 Aug;20(4):326-331.e1. doi: 10.1016/j.clbc.2020.02.008. Epub 2020 Feb 27.
  21. Zvizdic Z, Milisic E, Skenderi F, Sefic Pasic I, Vranic S. A free terminal ileal perforation as the presenting sign of Crohn’s disease in an adolescent female. Central Eur J Paediatr 2020;16(1):83-4, https://doi.org/10.5457/p2005-114.259.
  22. AlAhmad YFM, Abdelhafez IHE, Cyprian FS, Skenderi F, Akhtar S, Vranic S. A critical appraisal of predatory journals in pathology. J Clin Pathol 2020;73(1):58-60. doi: 10.1136/jclinpath-2019-206245.
  23. Karin-Kujundzic V, Kardum V, Sola IM, Paic F, Skrtic A, Skenderi F, Serman S, Nikuseva-Martic N, Vranic S, Serman L. Dishevelled family proteins in human placentas and serous ovarian carcinomas: A clinicopathologic and molecular study. APMIS. 2020 Mar;128(3):201-210. doi: 10.1111/apm.13012. Epub 2020 Jan 28.
  24. Alaghehbandan R, Ulamec M, Martinek P, Pivovarcikova K, Michalova K, Skenderi F, Hora M, Michal M, Hes O. Papillary pattern in clear cell renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 23 cases. Ann Diagn Pathol. 2019 Feb;38:80-86. doi: 10.1016/j.anndiagpath.2018.11.004. Epub 2018 Nov 22.
  25. Dzinic SH, Mahdi Z, Bernardo MM, Vranic S, Beydoun H, Nahra N, Alijagic A, Harajli D, Pang A, Saliganan DM, Rahman AM, Skenderi F, Hasanbegovic B, Dyson G, Beydoun R, Sheng S. Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma. PLoS One. 2019 Apr 19;14(4):e0215089. doi: 10.1371/journal.pone.0215089. eCollection 2019.
  26. Imamovic D, Bilalovic N, Skenderi F, Beslagic V, Ceric T, Hasanbegovic B, Beslija S, Vranic S. Letter to the Editor/Response. Breast J. 2019 May;25(3):569. doi: 10.1111/tbj.13284. Epub 2019 Apr 13.
  27. Terlević R, Perić Balja M, Tomas D, Krušlin B, Vranic S, Skenderi F. Demirović A. Somatostatin receptor SSTR2A and SSTR5 expression in neuroendocrine breast cancer. Ann Diagn Pathol. 2019 Feb;38:62-66. doi: 10.1016/j.anndiagpath.2018.11.002. Epub 2018 Nov 20.
  28. Imamovic D, Bilalovic N, Skenderi F, Beslagic V, Ceric T, Hasanbegovic B, Beslija S, Vranic S. Reply Letter to the Editor. Breast J 2019;25(3):569.https://doi.org/10.1111/tbj.13284
  29. Imamovic D, Bilalovic N, Skenderi F, Beslagic V, Ceric T, Hasanbegovic B, Beslija S, Vranic S. A Clinicopathologic Study of Invasive Apocrine Carcinoma of the Breast: A single center experience. Breast J. 2018 Nov;24(6):1105-1108. doi: 10.1111/tbj.13140. Epub 2018 Sep 21.
  30. Kardum V, Karin V, Glibo M, Skrtic A, Nikuseva Martic T, Ibisevic N, Skenderi F, Vranic S, Serman L. Methylation-associated silencing of SFRP1 gene in high-grade serous ovarian carcinomas. Ann Diagn Pathol. 2017 Dec;31:45-49. DOI: http://dx.doi.org/10.1016/j.anndiagpath.2017.07.002
  31. Petersson F, Martinek P, Vanecek T, Pivovarcikova K, Peckova K, Ondic O, Perez-Montiel D, Skenderi F, Ulamec M, Nenutil R, Hora M, Svoboda T, Rotterova P, Dusek M, Michal M, Hes O. Renal Cell Carcinoma With Leiomyomatous Stroma: A Group of Tumors With Indistinguishable Histopathologic Features, But 2 Distinct Genetic Profiles: Next-Generation Sequencing Analysis of 6 Cases Negative for Aberrations Related to the VHL gene. Appl Immunohistochem Mol Morphol. 2017 Oct 27. doi: 10.1097/PAI.0000000000000410. [Epub ahead of print].
  32. Skenderi F, Ulamec M, Vanecek T, Martinek P, Alaghehbandan R, Pane Foix M, Babankova I, Perez Montiel D, Alavarado-Cabrero I, Svajdler M, Dubinsky P, Cempirkova D, Pavlovsky M, Vranic S, Daum O, Ondic O, Pivovarcikova K, Michalova K, Hora M, Rotterova P, Stehlikova A, Michal M, Dusek M, Hes O. Warthin-like papillary renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 11 cases. Ann Diagn Pathol 2017;27:48-56. DOI: http://dx.doi.org/10.1016/j.anndiagpath.2017.01.005
  33. Michal M, Kazakov D, Agaimy A, Hosova M, Michalova K, Grossmann P, Steiner P, Skenderi F, Vranic S, Michal M. Whorling Cellular Perineurioma: A previously undescribed variant closely mimicking monophasic fibrous synovial sarcoma. Ann Diagn Pathol 2017;27:74-8. DOI: http://dx.doi.org/10.1016/j.anndiagpath.2017.02.001
  34. Peckova K, Martinek P, Pivovarcikova K, Vanecek T, Alaghehbandan R, Prochazkova K, Perez Montiel D, Hora M, Skenderi F, Ulamec M, Rotterova P, Daum O, Ferda J, Davidson W, Ondic O, Dubova M, Michal M, Hes O. Cystic and necrotic papillary renal cell carcinoma: prognosis, morphology, immunohistochemical, and molecular-genetic profile of 10 cases. Ann Diagn Pathol. 2017 Feb;26:23-30. DOI: http://dx.doi.org/10.1016/j.anndiagpath.2016.10.007
  35. Foix MP, Dunatov A, Martinek P, Mundó EC, Suster S, Sperga M, Lopez JI, Ulamec M, Bulimbasic S, Montiel DP, Alaghehbandan R, Peckova K, Pivovarcikova K, Ondrej D, Rotterova P, Skenderi F, Prochazkova K, Dusek M, Hora M, Michal M, Hes O. Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant. Virchows Arch. 2016 Dec;469(6):669-678. http://dx.doi.org/10.1007/s00428-016-2022-x
  36. Skenderi F, Chikha A, Ibisevic N, Tatarevic-Suko A, Kantardzic N, Vranic S. Skeletal Muscle Metastases from Squamous Cell Carcinoma of the Cervix: Report of Two Cases With Literature Review. Int J Gynecol Pathol. 2017 Jan;36(1):95-100. DOI: http://dx.doi.org/10.1097/PGP.0000000000000298
  37. Fabijanovic D, Zunic I, Nikuseva Martic T, Skenderi F, Serman L, Vranic S. The expression of SFRP1, SFRP3, DVL1 and DVL2 proteins in germ cell tumors of the testis. APMIS. 2016 Nov;124(11):942-949. DOI: http://dx.doi.org/10.1111/apm.12588
  38. Damjanov I, Skenderi F, Vranic S. Mammary Analogue Secretory Carcinoma (MASC) of the salivary gland: A new tumor entity. Bosn J Basic Med Sci. 2016 Aug 2;16(3):237-8. DOI: http://dx.doi.org/10.17305/bjbms.2016.1321
  39. Ulamec M, Skenderi F, Trpkov K, Kruslin B, Vranic S, Bulimbasic S, Trivunic S, Perez Montiel D, Peckova K, Pivovarcikova K, Ondic O, Daum O, Rotterova P, Hora M, Michal M, Hes O. Solid papillary renal cell carcinoma: Clinicopathologic, morphologic and immunohistochemical analysis of 10 cases and review of the literature. Ann Diagn Pathol. 2016 Aug;23:51-7. DOI: http://dx.doi.org/10.1016/j.anndiagpath.2016.04.008
  40. Pivovarcikova K, Peckova K, Martinek P, Montiel DP, Kalusova K, Pitra T, Hora M, Skenderi F, Ulamec M, Daum O, Rotterova P, Ondic O, Dubova M, Curik R, Dunatov A, Svoboda T, Michal M, Hes O. “Mucin”-secreting papillary renal cell carcinoma: clinicopathological, immunohistochemical, and molecular genetic analysis of seven cases. Virchows Arch. 2016 Jul;469(1):71-80. DOI: http://dx.doi.org/10.1007/s00428-016-1936-7
  41. Redzepagic J, Skenderi F, Bajrovic J, Beslagic V, Ibisevic N, Vranic S. Low-grade malignant peripheral nerve sheath tumor of the breast: A report of the first case and literature review. APMIS 2016; 124:428-430. DOI: http://dx.doi.org/10.1111/apm.12515.
  42. Ulamec M, Skenderi F, Zhou M, Krušlin B, Martínek P, Grossmann P, et al. Molecular Genetic Alterations in Renal Cell Carcinomas With Tubulocystic Pattern: Tubulocystic Renal Cell Carcinoma, Tubulocystic Renal Cell Carcinoma With Heterogenous Component and Familial Leiomyomatosis-associated Renal Cell Carcinoma. Clinicopathologic and Molecular Genetic Analysis of 15 Cases. Appl Immunohistochem Mol Morphol. 2016 Aug;24(7):521-30. DOI: http://dx.doi.org/10.1097/PAI.0000000000000213
  43. Damjanov I, Vranic S, Skenderi F. Does everything a surgeon takes out have to be seen by a pathologist? A review of the current pathology practice. Virchows Archiv. 2016;468(1):69-74. http://dx.doi.org/10.1007/s00428-015-1801-0
  44. Skenderi F, Vranic S, Damjanov I. Regulated cell death in diagnostic histopathology. Int J Dev Biol. 2015;59(1-3):149-58. doi: http://dx.doi.org/10.1387/ijdb.150037fs.
  45. Skenderi F, Ulamec M, Vranic S, Bilalovic N, Peckova N, Rotterova P, et al. Cystic renal oncocytoma and tubulocystic renal cell carcinoma. Morphological and immunohistochemical study. Appl Immunohistochem Mol Morphol. 24(2):112-9. doi: http://dx.doi.org/10.1097/PAI.0000000000000156.
  46. Skenderi F, Krakonja F, Vranic S. Infarcted fibroadenoma of the breast: Report of two cases with review of the literature. Diagn Pathol 2013;8(1):38. DOI: http://dx.doi.org/10.1186/1746-1596-8-38
  47. Udovicic-Gagula D, Skenderi F, Gornjakovic S, Ibisevic N, Chikha A, Vranic S, Đuran A. Uterine cervix squamous cell carcinoma metastatic to the Ampulla of Vater: a case report with review of the literature. Journal of Health Sciences. 2013;3(2):173-176. DOI: http://dx.doi.org/10.17532/jhsci.2013.84
  48. Skenderi F, Jonjic S. Viral vaccines and vectors–some lessons from cytomegaloviruses. Periodicum biologorum. 2012;114(2):201-210 [PDF]
  49. Mehic B, Valjevac A, Skenderi F. First decade of publishing of Bosnian Journal of Basic Medical Sciences. Bosn J Basic Med Sci. 2011;11(4):201-204. PMC: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362571/
  50. Kiseljakovic E, Jadric R, Hasic S, Skenderi F, Resic H, Winterhalter-Jadric M. Polymorphism in methylentetra-hydrofolate reductase gene: important role in diseases. Bosn J Basic Med Sci. 2008;8(2):165-169. https://dx.doi.org/10.17305/bjbms.2008.2975

Conference papers

  1. Tomić K, Pedersen S, Skenderi F, Ibišević N, Karan Križanac D, Vrdoljak E, Berić Jozić G, Pezer Naletilić M, HonoréB, Vranic S. Proteomic profiling and correlation with clinicopathological characteristics of patients with small cell lung cancer: a pilot study. Libri Oncologici 2023;51(suppl.1):77-8
  2. Alaghehbandan R, Agaimy A, Ali L, Alvarado-Cabrero I, Amin MB, Boudova L, Caliò A, Comperat EM, Damjanov I, Daum O, Farcas M, Gatalica Z, Gill AJ, Hartmann A, Hayes MM, Hora M, Kojima F, Kristiansen G, Kuroda N, López JI, Maclean F, Magi-Galluzzi C, Martignoni G, McKenney JK, Michalová K, Michal M, Mohanty SK, Netto GJ, Ohashi R, Ondič O, Osunkoya AO, Gomez MDPM, Petersson F, Picken MM, Pivovarcikova K, Rogala J, Shah RB, Siadat F, Skenderi F, Sperga M, Suster SM, Svajdler M, Tretiakova M, Trpkov K, Ulamec M, Williamson SR, Yang XJ, Zhou M, Vranic S, Vujanic G, Michal M. A tribute to Prof. Ondrej Hes, MD, PhD (1968–2022). Mod Pathol (2022). https://doi.org/10.1038/s41379-022-01159-8
  3. Skenderi F, Alahmad MAM, Alahamd YM, Abdelhafez IHE, Gatalica Z, Vranic S. HER2-positive Apocrine Carcinoma of the Breast: A population-based Analysis of Incidence, Treatment, and Outcome. Virchows Arch 2020, suppl.,(ECP/IAP presentation, December 2020).
  4. Skenderi F, Palazzo J, Swensen J, Contreras E, Florento E, Gatalica Z, Vranic S. Molecular Profiling of Clear Cell Carcinoma of the Breast Reveals Novel Targetable Biomarkers. Mod Pathol 2020;33(suppl.2):263. (Poster#267, USCAP 2020, Los Angeles).
  5. Gupta I, Jabeen A, Skenderi F, Malki MI, Al-Thawadi H, Al Moustafa AE, Vranic S. High-risk Human Papillomaviruses (HPV) and Epstein – Barr virus (EBV) are Commonly Present in Rectal Cancer. Mod Pathol 2020;33(suppl.2):676. (Poster#683, USCAP 2020, Los Angeles).
  6. S Beslija, T Ceric, B Hasanbegovic, F Skenderi, J Alidžanović, D Kopric, I Marjanović, A Mekic-Abazovic, IS Sisic, M Hammami, A Pasic, A Rasic, E Kapisazović. Effects of delayed initiation of adjuvant trastuzumab for non-metastatic, HER2 positive breast cancer in a limited resources setting: ML25232 study final results. Annals of Oncology 2019;30(supp5):v68 https://doi.org/10.1093/annonc/mdz240.025.
  7. Gatalica S, Vranic S, Stafford P, Skenderi F, Swensen J, Xiu J, Spetzler D. Spindle cell carcinoma of the breast: rare cancer with potentially targetable biomarkers. Ann Oncol 2019;30(suppl.3):mdz095.057, https://doi.org/10.1093/annonc/mdz095.057
  8. A Chikha, N Ibisevic, F Skenderi, S Bajramovic. Granulomatous inflammation after intravesical BCG immunotherapy for bladder cancer. Virchows Archiv 2019;475:S430-S430
  9. Chikha A, Ibisevic N, Skenderi F, Junuzovic D, Vranic S. A bilateral sex-cord stromal tumor of the testis. Report of the case. Abstractbook of Posters and Oral Presentations, XXXII Congress of the International Academy of Pathology, P-18, Abstract No. 10, Amman 2018.
  10. Ibrahim Abdelhafez, Yaman M. Alahmad, Faruk Skenderi, Semir Vranic. Predatory Journals in Oncology: A Critical Appraisal.  2nd World Congress on Undergraduate Research, Oldenburg, Germany, 2018
  11. V Karin, A Skrtic, F Skenderi, N Ibisevic, S Vranic, L Serman. DNA promoter methylation status and protein expression of SHh and IHh in serous ovarian carcinomas. Annals of Oncology, 2018;29(3).https://doi.org/10.1093/annonc/mdy047.016
  12. AlAhmad YFM, Abdelhafez IHE, Cyprian FS, Skenderi F, Akhtar S, Vranic S. Predatory journals in pathology: A comprehensive assessment. Abstractbook of Posters and Oral Presenations, XXXII Congress of the International Academy of Pathology, FOP-08-1, Abstract No. 003, Amman, 2018.
  13. Semir Beslija, Anes Pasic, Elma Kapisazovic, Berisa Hasanbegovic, Emir Sokolovic, Faruk Skenderi, Timur Ceric. Neoadjuvant trastuzumab + pertuzumab in HER2 positive breast cancer in a country with limited resources: Evaluation of complete pathological response in a real world practice. Journal of Clinical Oncology 2018 36:15_suppl, e12661-e12661.
  14. Karin V, Skrtic A, Skenderi F, Ibisevic N, Vranic S, Serman L. The status of SHH and IHH in serous ovarian carcinomas. Ann Oncol 2018;31(suppl_3):mdy047.016. (TAT 2018 – Targeted Anticancer Therapies, Paris, March 2018).
  15. Karin-Kujundzic V, Kardum V, Skrtic A, Skenderi F, Vranic S, Serman L. Expression of Dishevelled family proteins DVL1, DVL2 and DVL3 in serous ovarian carcinomas. Proceedings of the 2nd Frankfurt Conference on Quality Control in Life Processes & 8th International p63/p73 Workshop, September 2-6, 2018, Proceedings, pp 112-3 (Poster P1-031)
  16. Ibisevic N, Chikha A, Humackic A, Guzin Z, Bilalovic N, Vranic S, Skenderi F.  Diagnostic performance and concordance of histological and radiological findings on breast core needle biopsy: three years’ experience. (XXXII Congress of International Academy of Pathology, Amman, 2018)
  17. Masic S, Bacalja J, Vucic M, Cupic H, Tomas D, Ulamec M, Spajic B, Skenderi F, Kruslin B. Correlation of expression of Tgf-ß, Mmp2 and Lmo2 between prostatic adenocarcinoma and adjacent unaffected parenchyma. Virchows Arch 2018, suppl., in press. (30th European Congress of Pathology, Bilbao 2018)
  18. Ulamec M, Bacalja J, Masic S, Dzombeta T, Stimac G, Tomaskovic I, Skenderi F, Kruslin B. Clefting and the expression of E-cadherin and Lmo2 in prostatic adenocarcinoma. Virchows Arch 2018, suppl., in press. (30th European Congress of Pathology, Bilbao 2018)
  19. Terlevic R, Perić Balja M, Tomas D, Kruslin B, Vranic S, Skenderi F, Demirovic A. Somatostatin receptor expression in neuroendocrine breast cancer. Virchows Arch 2018, suppl., in press. (30th European Congress of Pathology, Bilbao 2018)
  20. Semir Beslija, Anes Pasic, Elma Kapisazovic, Berisa Hasanbegovic, Emir Sokolovic, Faruk Skenderi, Timur Ceric. Neoadjuvant trastuzumab + pertuzumab in HER2 positive breast cancer in a country with limited resources: Evaluation of complete pathological response in a real world practice. Journal of Clinical Oncology 2018;36(15suppl):e12661
  21. Aida Catic, Amina Kurtovic-Kozaric, Ardis Sophian, Lech Mazur, Faruk Skenderi, Ondrej Hes, Stephen Rohan, Dinesh Rakheja, Jillene Kogan, Michael R Pins. Prevalence of KANK1-NTRK3 fusion in renal metanephric adenomas that lack BRAF mutations. Cancer Genetics 2018; 224:59
  22. AlAhmad YFM, Abdelhafez IHE, Cyprian FS, Skenderi F, Akhtar S, Vranic S. Predatory journals in pathology: A comprehensive assessment. IAP 2018 (Amman, Jordan)
  23. Karin V, Skrtic A, Skenderi F, Ibisevic N, Vranic S, Serman L. The status of SHH and IHH in serous ovarian carcinomas. Ann Oncol 2018;31(suppl_3):mdy047.016. (TAT 2018 – Targeted Anticancer Therapies, Paris, March 2018).
  24. Imamovic D, Bilalovic N, Skenderi F, Beslagic V, Ceric T, Hasanbegovic B, Beslija S, Vranic S. Clinicopathologic characteristics of invasive apocrine carcinoma of the breast: A single center experience from a country with limited resources. Eur J Cancer 2018, suppl., in press (EBCC-11, Barcelona 2018).
  25. Karin V, Kakarigi L, Skrtic A, Nikuseva Martic T, Ibisevic N, Skenderi F, Vranic S, Serman L. Sonic Hedgehog proteins are overexpressed in high-grade serous ovarian carcinomas. Libri Oncologici 2016;44(1):38.
  26. Karin V, Kardum V, Glibo M, Skrtic A, Nikuseva Martic T, Ibisevic N, Skenderi F, Vranic S, Serman L. Methylation-associated silencing of SFRP1 gene in high-grade serous ovarian carcinomas. 10th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine. Dubrovnik, June 19-24, 2017.
  27. Demirović A, Vranić S, Skenderi F, Perić Balja M, Ulamec M, Vučić M, Krušlin B. Primary neuroendocrine carcinoma of the breast: a diagnostic approach to the rare primary breast malignancy. J Neuroendocrinol 2017, suppl., in press. (14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease. 8-10 March 2017, Barcelona, Spain).
  28. Michal M, Kazakov DV, Agaimy A, Michalova K, Grossmann P, Skenderi F, Vranic S, Michal M. Whorling Cellular Perineurioma: An undescribed benign tumor mimicking monophasic fibrous synovial sarcoma. Mod Pathol 2017;30(supplement 2s):20A.
  29. Mahdi Z, Dzinic SH, Vranic S, Skenderi F, Sheng S, Beydoun R. Differential Expression and Subcellular Localization of Tumor Suppressor Maspin as a Diagnostic Marker in Gastroesophageal Junction Carcinoma and Its Precursors. Mod Pathol 2017;30(supplement 2s):185A.
  30. Karin V, Kakarigi L, Skrtic A, Nikuseva Martic T, Ibisevic N, Skenderi F, Vranic S, Serman L. Sonic Hedgehog proteins are overexpressed in high-grade serous ovarian carcinomas. Fourth Meeting of the Croatian Association for Cancer Research, November 3-4, 2016.
  31. Fabijanovic D, Zunic I, Nikuseva Martic T, Skenderi F, Serman L, Vranic S. The members of Wnt pathway SFRP1, SFRP3 and DVL1 are downregulated in testicular germ cell tumors. Virchows Arch 2016;469(suppl.1):S218-9.
  32. Skenderi F, Ibisevic N, Topcagic J, Bilalovic N, Vranic S. Breast cancer incidence, demographic, and pathological characteristics in Bosnia and Herzegovina. Virchows Arch 2016;469(suppl.1):S58.
  33. Skenderi F, Ulamec M, Vranic S, Michal M, Hes O. Warthin-like papillary renal cell carcinoma with prominent lymphocytic infiltrate: Morphologic and immunohistochemical study. Virchows Arch 2016;469(suppl.1):S14.
  34. Ibisevic N, Skenderi F, Chikha A, Bilalovic N, Vranic S. Cervical cancer incidence, demographic and pathologic characteristics in Bosnia and Herzegovina. Virchows Arch 2016;469(suppl.1):S289.
  35. Chikha A, Ibisevic N, Skenderi F, Bilalovic N, Kulovac B, Selimović M, Vranic S. Spermatocytic seminoma: Report of three cases. Virchows Arch 2016; 469(suppl.1):S236.
  36. Cesarec S, Kirgin MS, Skenderi F, Ulamec M, Stimac G, Chikha A, Vranic S, Kruslin B. Sarcomatoid variant of urothelial carcinoma of the urinary bladder. A study of 27 cases. Virchows Arch 2015;467(suppl.1):S263.
  37. Skenderi F, Ulamec M, Vranic S, Bilalovic N, Peckova K, Rotterova P, Kokoskova B, Branzovsky J, Michal M, Hes O. Cystic renal oncocytoma and tubulocystic renal cell carcinoma: Morphological and immunohistohemical study. Pathology 2014;46(S2):135-6.
  38. Chikha A, Jukovic Bihorac F, Skenderi F, Krakonja F, Bilalovic N, Vranić S. Infarcted fibroadenoma of the breast: report of two cases. Histopathology.

Books/Chapters

  1. Ivan Damjanov, Semir Vranic, Faruk Skenderi. Review of Gynecologic and Breast Pathology. Jaypee Brother Medical Publishers (P) Ltd. 2017. URL: Amazon, Book Depository, Wisepress

Other publications

  1. AlAhmad YFM, Abdelhafez IHE, Skenderi F, Vranic S. When progress becomes predation. The Pathologist 2019, https://thepathologist.com/outside-the-lab/when-progress-becomes-predation

**********

Updated September, 2023